Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07442513) titled 'Comparison of Etamsylate Versus Placebo to Prevent Bleeding in HSCT' on Feb. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: First Affiliated Hospital of Zhejiang University
Condition:
Hematopoietic Stem Cell Transplantation
Thrombocytopenia
Intervention:
Drug: etamsylate
Recruitment Status: Recruiting
Phase: Phase 3
Date of First Enrollment: December 16, 2025
Target Sample Size: 404
Countries of Recruitment:
China...